Sarcura
Latest round
- Seed
Last raised
- Nov 2022
Total raised
- $10M
Investors
- 7
About Sarcura
Based in Austria, and founded in 2019 by its CEO Daniela Buchmayr, and co-founders Dr. Erwin Gorjup, and Dr. Martin Fischlechner. Sarcura GmbH operates as a deep-tech company that develops an instrument platform for the manufacturing of advanced cell therapies. As of November 2022, the company has a team of 20 people. Sarcura GmbH offers an instrument platform that combines silicon chip technology and microfluidic processing to enable real-time process control and manipulation on a cellular level, enabling a fully automated and modular manufacturing system. The platform will help to treat metabolic or neurologic diseases.
Who invested in Sarcura
7 investors across 2 rounds
See all investors in Sarcura
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sarcura
Who invested in Sarcura?
Sarcura has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sarcura raised?
Sarcura has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Sarcura last raise money?
Sarcura's most recent round on record is a Seed, in Nov 2022.
What does Sarcura do?
Based in Austria, and founded in 2019 by its CEO Daniela Buchmayr, and co-founders Dr.
Where is Sarcura headquartered?
Sarcura is headquartered in Austria.
Which VCs invest in companies like Sarcura?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Sarcura's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Sarcura? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.